ANO1 and cystic fibrosis: TSBs have been used to target miR-101 and miR-145 in the CFTR 3′ UTR, thus increasing CFTR expression and function in CF nasal epithelial cells as well as correcting chloride efflux mediated by ANO1 [53,57].